Information  X 
Enter a valid email address

GlaxoSmithKline PLC (GSK)

  Print      Mail a friend       Annual reports

Friday 20 February, 2015

GlaxoSmithKline PLC

Director/PDMR Shareholding

RNS Number : 4896F
GlaxoSmithKline PLC
20 February 2015

GlaxoSmithKline plc


Notification of Transactions of Directors, Persons Discharging Managerial Responsibility or Connected Persons



In accordance with DTR 3.1.4 R(1)(a) and (c) GlaxoSmithKline plc (GSK) was advised on 20 February 2015 of the following increase in the notional allocation of GSK American Depositary Shares (ADSs) on 19 February 2015, at a price of $47.03 per ADS, following the revaluation of the cash element of the notional investment held within the GSK 401K plan:





Number of ADSs


Mr W C Louv




Dr M M Slaoui






Connected person


Number of ADSs


Dr K Slaoui (connected person of Dr M M Slaoui)






V A Whyte

Company Secretary


20 February 2015


This information is provided by RNS
The company news service from the London Stock Exchange

a d v e r t i s e m e n t